Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
03/2012
03/29/2012CA2809557A1 Pyrazolopyridines as inhibitors of the kinase lrrk2
03/29/2012CA2809217A1 Pyrimidones for treatment of potassium channel related diseases
03/28/2012EP2433940A1 Spiroimidazolone derivative
03/28/2012EP2433939A1 Substituted 8-sulfonyl-2,3,4,5-tetrahydro-1h-gamma-carbolines, ligands and pharmaceutical composition; method for the production and use of same
03/28/2012EP2433937A1 Substituted-quinoxaline-type-piperidine compounds and the uses thereof
03/28/2012EP2433936A1 Substituted-quinoxaline-type-piperidine compounds and the uses thereof
03/28/2012EP2433935A1 Substituted-quinoxaline-type-piperidine compounds and the uses thereof
03/28/2012EP2432782A1 Methods for the identification of phosphatidylinositol kinase interacting molecules and for the purification of phosphatidylinositol kinase proteins
03/28/2012EP2432779A1 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases
03/28/2012EP2432766A1 Anticancer compound and pharmaceutical composition containing the same
03/28/2012EP2432318A1 Bimacrocyclic hcv ns3 protease inhibitors
03/28/2012EP2297148B8 Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors
03/28/2012EP2252612B1 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors
03/28/2012EP2148862B1 Dihydroquinone and dihydronaphthridine inhibitors of jnk
03/28/2012EP1956008B1 Organic compound, charge-transporting material, composition for charge-transporting material and organic electroluminescent device
03/28/2012EP1951690B1 Heterocyclic cetp inhibitors
03/28/2012EP1432707B1 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
03/28/2012CN102395589A Fused pyrrolopyridine derivative
03/28/2012CN102395588A Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1
03/28/2012CN102395587A Pyridocarbazole type compounds and applications thereof
03/28/2012CN102395586A TRiazolopyridine derivatives as p38 map kinase inhibitors
03/28/2012CN102395585A Heteroaryls and their use as pi3k inhibitors
03/28/2012CN102395562A Novel p2x7r antagonists and their use
03/28/2012CN102391309A Ruthenium coordination compound based on unit containing naphthalimide and synthesis method thereof
03/28/2012CN102391266A Method for extracting and separating pseudolycorine from lycoris plants
03/28/2012CN102391265A Method for extracting antofine
03/28/2012CN102391264A Preparation method of 6-bromoimidazo [1,2-a] pyridine
03/28/2012CN102391255A Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
03/28/2012CN102391107A Method for preparing gallic acid quinolone drug salt and preparation method thereof
03/27/2012USRE43274 Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy
03/27/2012US8143394 Pyrido(3,2-d)pyrimidines useful for treating viral infections
03/27/2012US8143300 Inhibitors of cellular necrosis
03/27/2012US8143272 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
03/27/2012US8143271 Compounds and methods for kinase modulation, and indications therefor
03/27/2012US8143270 2-amino 1H-in-imidazo ring systems and methods
03/27/2012US8143255 Heteroalkyl linked pyrimidine derivatives
03/27/2012US8143057 Chelating agents and highly luminescent and stable chelates and their use
03/27/2012CA2682329C Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists
03/27/2012CA2540541C Alkoxy substituted imidazoquinolines
03/22/2012WO2012037226A1 Inhibitors of pi3k-delta and methods of their use and manufacture
03/22/2012WO2012037132A1 Phtalazine derivatives as jak1 inhibitors
03/22/2012WO2012037060A1 Substituted azaindoles
03/22/2012WO2012036278A1 Glycine transporter inhibitor
03/22/2012WO2012036253A1 Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine.
03/22/2012WO2012036233A1 Condensed heterocyclic derivative having melanine-concentrating hormone receptor antagonistic activity
03/22/2012WO2012036185A1 Metal complex, alteration product thereof, and compound useful in same
03/22/2012WO2012035554A1 An improved process for the preparation of highly pure paliperidone
03/22/2012WO2012035078A1 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS
03/22/2012WO2012034526A1 Fused heteroaryls and their uses
03/22/2012WO2011154586A3 Improved methods for the preparation of quinoxaline derivatives
03/22/2012US20120071657 Triazole compounds useful as protein kinase inhibitors
03/22/2012US20120071494 Pyrazolopyridine kinase inhibitors
03/22/2012US20120071493 Substituted 8-sulfonyl-2,3,4,5-tetrahydro-1h-gamma-carbolines, ligands and pharmaceutical composition; method for the production and use of same
03/22/2012US20120071483 Therapeutic approaches for treating alzheimer disease and related disorders through a modulation of cell stress response
03/22/2012US20120071482 Heteroaryl compounds useful as inhibitors of e1 activating enzymes
03/22/2012US20120071479 Pyrazine derivatives as enac blockers
03/22/2012US20120071475 Urea derivatives having pi3k-inhibiting activity
03/22/2012US20120071474 Inhibitors of pi3 kinase
03/22/2012US20120071463 Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods
03/22/2012US20120071460 Pyrazole oxadiazole derivatives as s1p1 agonists
03/22/2012US20120071459 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
03/22/2012US20120071322 Substituted Pyridopyrazines with a Herbicidal Action
03/22/2012US20120070409 Tetracyclic fused heterocyclic compound and use thereof as hcv polymerase inhibitor
03/22/2012US20120068164 Material for organic electroluminescent element and organic electroluminescent element employing the same
03/22/2012CA2812091A1 Inhibitors of pi3k-delta and methods of their use and manufacture
03/22/2012CA2812088A1 Phtalazine derivatives as jak1 inhibitors
03/22/2012CA2811080A1 Heterocyclic compound
03/22/2012CA2810708A1 Fused heteroaryls and their uses
03/21/2012EP2431369A2 Carboline derivatives useful in the inhibition of angiogenesis
03/21/2012EP2430031A1 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
03/21/2012EP2430023A1 Azacyclic spiroderivatives as hsl inhibitors
03/21/2012EP2430022A1 1,2,3-triazolo ý4,3-a¨pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
03/21/2012EP2430021A1 7-aryl-1,2,4-triazoloý4,3-a¨pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
03/21/2012EP2430015A1 Fused tricyclic aryl compounds useful for the treatment of viral diseases
03/21/2012EP2430013A1 Heteroaryl compounds as pikk inhibitors
03/21/2012EP2429993A1 Inhibitors of human immunodeficiency virus replication
03/21/2012EP2429529A1 Solid forms and process for preparing
03/21/2012EP2429296A1 7-([1,2,4,]triazolo[1,5,-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4- tetrahydroisoquinoline and use thereof
03/21/2012EP2429295A1 Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
03/21/2012EP1921917B1 Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
03/21/2012EP1910364B1 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
03/21/2012CN102388043A Histamine h3 inverse agonists and antagonists and methods of use thereof
03/21/2012CN102388042A Spiroheterocyclic pyrrolidine dione derivatives used as pesticides
03/21/2012CN102388041A 2-morpholino-pyrido[3,2-d]pyrimidines
03/21/2012CN102386333A Laminated organic thin film solar cell
03/21/2012CN102382170A Method for preparation of protease inhibitors and intermediates
03/21/2012CN102382129A Spirocycles-substituted phosphodiesterase inhibitor
03/21/2012CN102382112A Compound for curing tumors, preparation method and application thereof
03/21/2012CN102382111A Sulfo-tetrahydro-pyridino-dihydro-pyrimidone derivative, preparation method for same and application thereof
03/21/2012CN102382110A Preparation method of phen complexing agent
03/21/2012CN102382109A Preparation method of 1,8-dinitro-9-fluorenone
03/21/2012CN102382106A Aniline substituted quinazoline derivative
03/21/2012CN102382065A Aniline substituted quinazoline derivative
03/21/2012CN102379872A Compounds, compositions and methods of inhibiting a-synuclein toxicity
03/21/2012CN101712681B Chemical synthesis method of paliperidone intermediate
03/21/2012CN101370808B Tetrabenzodiazadiketoperylene colourants in ir-reflective coatings and plastics
03/21/2012CN101045728B Preparation method and use of compound with high insecticidal activity
03/21/2012CN101007803B Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
03/20/2012US8138333 Sulfonyl-indole derivatives
03/20/2012US8138181 Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
1 ... 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 ... 646